Abstract
Background and purpose DNA ploidy and cell cycle measurements of uveal melanoma tissue are regarded as having limited prognostic significance. In contrast, dual-parameter (DNA monoclonal antibody) flow cytometry offers a convenient and rapid way to screen tumour samples for a variety of phenotypic markers, whilst simultaneously measuring DNA ploidy and cell cycle, and therefore has the increased potential to identify clinically relevant indicators of disease progression. The aim of the present study was to identify a simple yet robust method for isolating, preserving and staining cells that could be analysed by flow cytometry.
Methods Using a simple preparation procedure, a panel of membrane-associated antibodies (ICAM-1, W632, HLA-DR) and nuclear or cytoplasmic oncoprotein antibodies (c-erbB-2, c-myc, bcl-2, p53), together with positive (PHM-5) and negative (FITC F(ab′)2) controls, were assayed. It was considered important to test the protocol with markers expressed on the cell surface, and in the cytoplasm and nucleus, so as not to be restrictive and thereby exclude an antigen of potential clinical interest. In addition, such panels would also enable the generation of a ‘phenotypic profile’ for each specimen that may reveal clinically significant trends.
Results Our results indicate that tissue dissociation followed by brief fixation in 1% paraformaldehyde and permeabilisation in 70% methanol produces a stable single cell suspension, which can subsequently be stained with a wide range of antibodies for the accurate identification of cells in a potentially heterogeneous tumour population.
Conclusion This technology can rapidly identify sub-populations of cells expressing differing levels of proteins, which may prove to be indicative of disease progression for this aggressive disease.
Similar content being viewed by others
Article PDF
References
Egan KM, Seddon JM, Glynn RJ, Gragoudas ES, Albert DM . Epidemiologic aspects of uveal melanoma. Surv Ophthalmol 1988;32:239–57.
Char DH, Huhta K, Waldman F . DNA cell cycle studies in uveal melanoma. Am J Ophthalmol 1989;107:65–72.
Rennier IG, Rees RC, Parsons MA, Lawry J, Cottam D . Estimation of DNA content in uveal melanoma by flow cytometry. Eye 1989;3:611–7.
Richardson RPS, Lawry J, Rees RC, Rennie IG . DNA index and % proliferation in posterior uveal melanoma: a 5-year prospective study of fresh tissue using flow cytometry. Eye 1997;11:629–34.
Muhonen T, Pyrhonen S, Laasonen A, Asko-Seljavaara S, Franssila K . DNA aneuploidy and low S-phase fraction as favourable prognostic signs in metastatic melanoma. Br J Cancer 1991;64:749–52.
Bartkowiak D, Otto F, Schumann J, Lippold A, Drepper H . Sequential DNA flow cytometry in metastatic malignant melanoma. Oncology 1991;48:154–7.
Mooy C, Vissers K, Luyten G, Mulder A, Stijnen T, de Jong F, Bosman F . DNA flow cytometry in uveal melanomas: the effect of pre-enucleation irradiation. Br J Ophthalmol 1995;79:174–7.
Lawry J, Rogers K, Duncan JL, Potter CW . The identification of informative parameters in the flow cytometric analysis of breast carcinoma. Eur J Cancer 1993;29:719–23.
Nowak R, Oelschlaegel U, Schuler U, Zengler H, Hofmann R, Ehninger G, Andreeff M . Sensitivity of combined DNA/ immunophenotype flow cytometry for the detection of low levels of aneuploid lymphoblastic leukaemia cells in bone marrow. Cytometry (Commun Clin Cytometry) 1997;30:47–53.
Feitz WFJ, Karthaus HFM, Beck HLM, Romun C, Van Der Meyden APM, Debruyne FMJ, et al. Tissue-specific markers in flow cytometry of urological cancers. II. Cytokeratin and vimentin in renal-cell tumours. Int J Cancer 1986;37:201–7.
Park CH, Kimler BF . Tumour cell-selective flow cytometric analysis for DNA content and cytokeratin expression of clinical tumour specimens by ‘cross-gating’. Anti-cancer Res 1994;14:29–36.
Carrel S, Schreyer M, Gross N, Zografos L . Surface antigenic profile of uveal melanoma lesions analysed with a panel of monoclonal antibodies directed against cutaneous melanoma. Anti-cancer Res 1990;10:81–90.
Jager MJ, Van der Pol JP, de Wolff-Rouendaal D, De Jong PTVM, Ruiter DJ . Decreased expression of HLA Class II antigens on human uveal melanoma cells after in vivo X-ray irradiation. Am J Ophthalmol 1988;105:78–86.
Waard-Siebinga I, Houbiers JGA, Hilders CGJM, Wolff-Rouendaal D, Jager MJ . Differential expression of HLA-A and B-alleles on uveal melanoma as determined by immunohistology. Ocular Immunol Inflammation 1996;4:1–14.
Zaloudik J, Moore M, Ghosh AK, Mechl Z, Rejthar A . DNA content and MHC class II antigen expression in malignant melanoma: clinical course. J Clin Pathol 1988;41:1078–84.
Natali PG, Bigotti A, Nicotra MR, Nardi RM, Delovu A, Segatto O, Ferrone S . Analysis of the antigenic profile of uveal melanoma lesions with anti-cutaneous melanomaassociated antigen and HLA monoclonal antibodies. Cancer Res 1989;49:1269–74.
Tran JM, Murray TG, Uno T, Valore N, Ksander BR . Expression of HLA Class I on ocular melanoma during progression from primary to metastatic disease. Invest Ophthalmol Vis Sci 1996;37:s208.
Juliano RL . The role of β1 integrins in tumours. Semin Cancer Biol 1993;4:277–83.
Cottam DW, Rennie IG, Woods K, Parsons A, Bunning RAD, Rees RC . Gelatinolytic metalloproteinase secretion patterns occur in ocular melanoma. Invest Ophthalmol Vis Sci 1992;33:1923–7.
Cottam DW, Rees RC . Regulation of matrix metalloproteinases: their role in tumour invasion and metastases. Int J Oncol 1993;2:861–72.
Johnson JP, Stade BG, Holzmann B, Schwable W, Riethmuller G . De novo expression of intercellular-adhesion molecule 1 in melanoma correlates with increased risk of metastases. Proc Natl Acad Sci USA 1989;86:641–4.
Natali P, Nicotra MR, Cavaliere R, Bigotti A, Romano G, Temponi M, Ferrone S . Differential expression of intercellular adhesion molecule 1 in primary and metastatic melanoma lesions. Cancer Res 1990;50:1271–8.
Pezzella F, Tse AGD, Cordell JL, Pulford KAF, Gatter KC, Mason DY . Expression of the bcl-2 oncoprotein is not specific for the 14;18 chromosome translocation. Am J Pathol 1990;137:225–32.
Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ . bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990;348:334–6.
Author information
Authors and Affiliations
Corresponding author
Additional information
The flow cytometry unit in the University Medical School in Sheffield is generously funded by the Yorkshire Cancer Research Campaign
Rights and permissions
About this article
Cite this article
Lawry, J., Smith, M., Parsons, A. et al. Simultaneous cell cycle and phenotypic analysis of primary uveal melanoma by flow cytometry. Eye 12, 431–439 (1998). https://doi.org/10.1038/eye.1998.101
Issue Date:
DOI: https://doi.org/10.1038/eye.1998.101